Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOPs for Biosimilars V 2.0

Biosimilars: SOP for Limiting Dilution Cloning – V 2.0

Posted on By

To define a standard procedure for isolating single-cell-derived clones by limiting dilution cloning in order to establish monoclonal cell lines used in biosimilar product development.
Click to read the full article.

Biosimilars V 2.0

Biosimilars: SOP for Colony Screening and Expression Analysis – V 2.0

Posted on By

To define the standardized method for colony screening and initial expression analysis in transfected cell lines to identify and select high-producing biosimilar clones.
Click to read the full article.

Biosimilars V 2.0

Biosimilars: SOP for ELISA-Based Screening of Clones – V 2.0

Posted on By

To establish a standardized method for using Enzyme-Linked Immunosorbent Assay (ELISA) to screen biosimilar-producing cell clones based on protein expression levels in the culture supernatant.
Click to read the full article.

Biosimilars V 2.0

Biosimilars: SOP for Western Blotting for Protein Expression – V 2.0

Posted on By

To define the standardized procedure for detecting and analyzing biosimilar protein expression in cell lysates using SDS-PAGE followed by Western blotting during clone evaluation and selection.
Click to read the full article.

Biosimilars V 2.0

Biosimilars: SOP for Stable Cell Line Development – V 2.0

Posted on By

To establish a standardized procedure for the development of stable mammalian cell lines expressing biosimilar therapeutic proteins. This includes transfection, clone selection, expansion, and characterization steps.
Click to read the full article.

Biosimilars V 2.0

Biosimilars: SOP for Adaptation of Cells to Serum-Free Media – V 2.0

Posted on By

To describe the step-by-step procedure for adapting mammalian cell lines used in biosimilar production from serum-containing media to serum-free media to support regulatory compliance, scalability, and safety.
Click to read the full article.

Biosimilars V 2.0

Biosimilars: SOP for Gene Copy Number Determination – V 2.0

Posted on By

To establish a standardized method for determining the gene copy number of integrated biosimilar transgenes in cell lines using quantitative PCR (qPCR), aiding in clone selection and stability assessment.
Click to read the full article.

Biosimilars V 2.0

Biosimilars: SOP for Southern Blot Analysis – V 2.0

Posted on By

To define the method for performing Southern blot analysis for confirming transgene integration, determining gene copy number, and detecting rearrangements in genetically modified biosimilar-producing cell lines.
Click to read the full article.

Biosimilars V 2.0

Biosimilars: SOP for mRNA Transcript Analysis (RT-PCR) – V 2.0

Posted on By

To define the standard procedure for analyzing mRNA transcripts of biosimilar genes in transfected cell clones using reverse transcription polymerase chain reaction (RT-PCR).
Click to read the full article.

Biosimilars V 2.0

Biosimilars: SOP for Protein Expression Profiling – V 2.0

Posted on By

To define the procedure for evaluating biosimilar protein expression levels in engineered cell clones using SDS-PAGE, Western blotting, and densitometry techniques for clone selection and development decisions.
Click to read the full article.

Biosimilars V 2.0

Posts pagination

Previous 1 2 3 Next

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme